Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis-Reference-Cited by-同舟云学术

Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis

Published:2014-11 Issue:3 Volume:80 Page:222-226
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Tsai Hsih-Yeh,Chen Yen-Hsu,Tang Hung-Jen,Huang Chi-Chang,Liao Chun-Hsing,Chu Fang-Yeh,Chuang Yin-Ching,Sheng Wang-Huei,Ko Wen-Chien,Hsueh Po-Ren^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009–2011;Bouchillon;Clin Ther,2013

2. Vital signs: carbapenem-resistant Enterobacteriaceae;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2013

3. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J Chronic Dis,1987

4. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes;Chen;J Microbiol Immunol Infect,2012

5. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy;Chow;Ann Intern Med,1991

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic resistance and virulence profiles of Proteus mirabilis isolated from broiler chickens at abattoir in South Africa;Veterinary Medicine and Science;2024-02-15

2. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

3. Antibiotic stewardship in the ICU: time to shift into overdrive;Annals of Intensive Care;2023-05-06

4. Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis;International Journal of Infectious Diseases;2023-03

5. Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study;Journal of Antimicrobial Chemotherapy;2023-01-24